Sparse Gaussian processes and various extensions thereof are enabled through inducing
points, that simultaneously bottleneck the predictive capacity and act as the main contributor …

PURPOSE Early discontinuation affects more than one third of patients enrolled in early-phase
oncology clinical trials. Early discontinuation is deleterious both for the patient and for the …

PURPOSE Drug development in oncology currently is facing a conjunction of an increasing
number of antineoplastic agents (ANAs) candidate for phase I clinical trials (P1CTs) and an …

Model-based Reinforcement Learning estimates the true environment through a world model
in order to approximate the optimal policy. This family of algorithms usually benefits from …

The industry and investigators’ communities are currently facing a conjunction of increasing
number of anti-neoplastic agents (ANA) candidate for phase 1 clinical trials (P1CT) and an …

The scientific innovation in natural language processing (NLP) is at its fastest pace to date,
driven by advances in large language models (LLMs). LLMs power multipurpose chatbots, …

The Manifesta, which takes place every two years in a different European city, has a reputation
for being a place for creativity and innovation, and for good reason. Primarily responsible …

High-density lipoprotein (HDL) has been proposed to have several antiatherosclerotic
properties, including the ability to mediate macrophage cholesterol efflux, antioxidant capacity, …

… Charvet has received … Charvet has received personal compensation in the range of
$500-$4,999 for serving as a Consultant for Springer Healthcare. The institution of Dr. Charvet has …

Plasmodione (PD) is a potent antimalarial redox-active 3-benzyl-menadione acting at low
nanomolar range concentrations on different malaria parasite stages. The specific …